{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:37:18Z","timestamp":1766086638766},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,9,4]],"date-time":"2010-09-04T00:00:00Z","timestamp":1283558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,9,4]],"date-time":"2010-09-04T00:00:00Z","timestamp":1283558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s10637-010-9524-1","type":"journal-article","created":{"date-parts":[[2010,9,3]],"date-time":"2010-09-03T03:03:51Z","timestamp":1283483031000},"page":"105-113","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["3\u03b2-acetyl tormentic acid induces apoptosis of resistant leukemia cells independently of P-gp\/ABCB1 activity or expression"],"prefix":"10.1007","volume":"30","author":[{"given":"Gleice da Gra\u00e7a","family":"Rocha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisol","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Rodrigues","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Auxiliadora Coelho","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cerli Rocha","family":"Gattass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,4]]},"reference":[{"issue":"8 Suppl A","key":"9524_CR1","first-page":"4","volume":"13","author":"J Sessions","year":"2007","unstructured":"Sessions J (2007) Chronic myeloid leukemia in 2007. J Manag Care Pharm 13(8 Suppl A):4\u20137","journal-title":"J Manag Care Pharm"},{"key":"9524_CR2","unstructured":"American Cancer Society (2009) Cancer facts and figures\u00a02009. Annual publication of the American Cancer Society, Atlanta, Georgia. http:\/\/www.cancer.org\/downloads\/STT\/500809web.pdf"},{"key":"9524_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1040-8428(03)00173-2","volume":"50","author":"JM N\u00f8rgaard","year":"2004","unstructured":"N\u00f8rgaard JM, Olesen LH, Hokland P (2004) Changing picture of cellular drug resistance in human leukemia. Crit Rev Oncol Hematol 50:39\u201349. doi:10.1016\/S1040-8428(03)00173-2","journal-title":"Crit Rev Oncol Hematol"},{"key":"9524_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0163-7258(99)00073-X","volume":"85","author":"AK Larsen","year":"2000","unstructured":"Larsen AK, Escargueil AE, Skladanowski A (2000) Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 85:217\u2013229. doi:10.1016\/S0163-7258(99)00073-X","journal-title":"Pharmacol Ther"},{"issue":"1","key":"9524_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","volume":"455","author":"RL Juliano","year":"1976","unstructured":"Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455(1):152\u2013162. doi:10.1016\/0005-2736(76)90160-7","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"9524_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2217\/14622416.9.1.105","volume":"9","author":"FJ Sharom","year":"2008","unstructured":"Sharom FJ (2008) ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 9(1):105\u2013127. doi:10.2217\/14622416.9.1.105","journal-title":"Pharmacogenomics"},{"key":"9524_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cancergencyto.2005.01.015","volume":"162","author":"S Galimberti","year":"2005","unstructured":"Galimberti S, Cervetti G, Guerrini F, Testi R, Pacini S, Fazzi R, Simi P, Petrini M (2005) Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment. Cancer Genet Cytogenet 162:57\u201362. doi:10.1016\/j.cancergencyto.2005.01.015","journal-title":"Cancer Genet Cytogenet"},{"issue":"4","key":"9524_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1158\/1078-0432.CCR-06-2147","volume":"13","author":"HM Kantarjian","year":"2007","unstructured":"Kantarjian HM, Giles F, s-Cardama AQ, Cortes J (2007) Important therapeutic targets in chronic myelogenous leukemia. Clin Cancer Res 13(4):1089\u20131097. doi:10.1158\/1078-0432.CCR-06-2147","journal-title":"Clin Cancer Res"},{"issue":"6","key":"9524_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrc2147","volume":"7","author":"JV Melo","year":"2007","unstructured":"Melo JV, Barnes DJ (2007) Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 7(6):441\u2013453. doi:10.1038\/nrc2147","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"9524_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/CCO.0b013e3282f1fe8a","volume":"20","author":"D Milojkovic","year":"2008","unstructured":"Milojkovic D, Apperley J (2008) State-of-the-art in the treatment of chronic myeloid leukaemia. Curr Opin Oncol 20(1):112\u2013121. doi:10.1097\/CCO.0b013e3282f1fe8a","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"9524_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/sj.leu.2403664","volume":"19","author":"D Marin","year":"2005","unstructured":"Marin D, Kaeda J, Szydlo R, Saunders S, Fleming A, Howard J, Andreasson C, Bua M, Olavarria E, Rahemtulla A, Dazzi F, Kanfer E, Goldman JM, Apperley JF (2005) Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse. Leukemia 19(4):507\u2013512. doi:10.1038\/sj.leu.2403664","journal-title":"Leukemia"},{"key":"9524_CR12","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1182\/blood.V101.6.2368","volume":"101","author":"FX Mahon","year":"2003","unstructured":"Mahon FX, Belloc F, Lagarde V, Chollet C, Moreau-Gaudry F, Reiffers J, Goldman JM, Melo JV (2003) MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models. Blood 101:2368\u20132373","journal-title":"Blood"},{"key":"9524_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1006\/bcmd.2002.0492","volume":"28","author":"T Efferth","year":"2002","unstructured":"Efferth T, Davey M, Olbrich A, R\u00fccker G, Gebhart E, Davey R (2002) Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug- resistant human CCRF-CEM leukemia. Blood Cell Mol Dis 28:160\u2013168. doi:10.1006\/bcmd.2002.0492","journal-title":"Blood Cell Mol Dis"},{"issue":"2","key":"9524_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0304-3835(02)00593-1","volume":"190","author":"J Fernandes","year":"2003","unstructured":"Fernandes J, Castilho RO, da Costa MR, Wagner-Souza K, Coelho Kaplan MA, Gattass CR (2003) Pentacyclic triterpenes from Chrysobalanaceae species: cytotoxicity on multidrug resistant and sensitive leukemia cell lines. Cancer Lett 190(2):165\u2013169. doi:10.1016\/S0304-3835(02)00593-1","journal-title":"Cancer Lett"},{"issue":"1","key":"9524_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.canlet.2006.06.008","volume":"248","author":"F Braga","year":"2007","unstructured":"Braga F, Ayres-Saraiva D, Gattass CR, Capella MA (2007) Oleanolic acid inhibits the activity of the multidrug resistance protein ABCC1 (MRP1) but not of the ABCB1 (P-glycoprotein): possible use in cancer chemotherapy. Cancer Lett 248(1):147\u2013152. doi:10.1016\/j.canlet.2006.06.008","journal-title":"Cancer Lett"},{"issue":"23","key":"9524_CR16","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.1016\/j.bmc.2007.07.020","volume":"15","author":"G Rocha Gda","year":"2007","unstructured":"Rocha Gda G, Sim\u00f5es M, L\u00facio KA, Oliveira RR, Coelho Kaplan MA, Gattass CR (2007) Natural triterpenoids from Cecropia lyratiloba are cytotoxic to both sensitive and multidrug resistant leukemia cell lines. Bioorg Med Chem 15(23):7355\u20137360. doi:10.1016\/j.bmc.2007.07.020","journal-title":"Bioorg Med Chem"},{"key":"9524_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/mmr_00000095","volume":"2","author":"JM Delou","year":"2009","unstructured":"Delou JM, Capella MAM, Gattass CR (2009) Betulinic acid does not modulate the activity of P-gp\/ABCB1or MRP1\/ABCC1 in a non-tumoral renal cell line: possible utility in multidrug resistance cancer chemotherapy. Mol Med Rep 2:271\u2013275. doi:10.3892\/mmr_00000095","journal-title":"Mol Med Rep"},{"issue":"1","key":"9524_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1590\/S0001-37652001000100007","volume":"73","author":"VM Rumjanek","year":"2001","unstructured":"Rumjanek VM, Trindade GS, Wagner-Souza K, de-Oliveira MC, Marques-Santos LF, Maia RC, Capella MA (2001) Multidrug resistance in tumour cells: characterization of the multidrug resistant cell line K562-Lucena 1. An Acad Bras Cienc 73(1):57\u201369. doi:10.1590\/S0001-37652001000100007","journal-title":"An Acad Bras Cienc"},{"issue":"7","key":"9524_CR19","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/sj.leu.2403390","volume":"18","author":"R Tang","year":"2004","unstructured":"Tang R, Faussat AM, Majdak P, Perrot JY, Chaoui D, Legrand O, Marie JP (2004) Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1. Leukemia 18(7):1246\u20131251. doi:10.1038\/sj.leu.2403390","journal-title":"Leukemia"},{"issue":"3","key":"9524_CR20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","volume":"45","author":"CB Lozzio","year":"1975","unstructured":"Lozzio CB, Lozzio BB (1975) Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45(3):321\u2013334","journal-title":"Blood"},{"issue":"2","key":"9524_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","volume":"139","author":"I Nicoletti","year":"1991","unstructured":"Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139(2):271\u2013279","journal-title":"J Immunol Methods."},{"issue":"1","key":"9524_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/0014-4827(88)90152-8","volume":"174","author":"AA Neyfakh","year":"1988","unstructured":"Neyfakh AA (1988) Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp Cell Res 174(1):168\u2013176. doi:10.1016\/0014-4827(88)90152-8","journal-title":"Exp Cell Res"},{"issue":"18","key":"9524_CR23","first-page":"5002","volume":"49","author":"K Yusa","year":"1989","unstructured":"Yusa K, Tsuruo T (1989) Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562\/ADM cells. Cancer Res 49(18):5002\u20135006","journal-title":"Cancer Res"},{"issue":"5\u20136","key":"9524_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cytogfr.2007.06.015","volume":"18","author":"LA Kujawski","year":"2007","unstructured":"Kujawski LA, Talpaz M (2007) The role of interferon-alpha in the treatment of chronic myeloid leukemia. Cytokine Growth Factor Rev 18(5\u20136):459\u2013471. doi:10.1016\/j.cytogfr.2007.06.015","journal-title":"Cytokine Growth Factor Rev"},{"key":"9524_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1470-2045(03)00979-3","volume":"4","author":"CB Gambacorti-Passerini","year":"2003","unstructured":"Gambacorti-Passerini CB, Gunby RH, Piazza R, Galietta A, Rostagno R, Scapozza L (2003) Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias. Lancet Oncol 4:75\u201385. doi:10.1016\/S1470-2045(03)00979-3","journal-title":"Lancet Oncol"},{"issue":"6","key":"9524_CR26","doi-asserted-by":"publisher","first-page":"530","DOI":"10.2174\/138945009788488468","volume":"10","author":"M Breccia","year":"2009","unstructured":"Breccia M, Alimena G (2009) Nilotinib therapy in chronic myelogenous leukemia: the strength of high selectivity on BCR\/ABL. Curr Drug Targets 10(6):530\u2013536","journal-title":"Curr Drug Targets"},{"issue":"2","key":"9524_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bcp.2009.04.002","volume":"78","author":"AK Tiwari","year":"2009","unstructured":"Tiwari AK, Sodani K, Wang SR, Kuang YH, Ashby CR Jr, Chen X, Chen ZS (2009) Nilotinib (AMN107, Tasigna) reverses multidrug resistance by inhibiting the activity of the ABCB1\/Pgp and ABCG2\/BCRP\/MXR transporters. Biochem Pharmacol 78(2):153\u2013161. doi:10.1016\/j.bcp.2009.04.002","journal-title":"Biochem Pharmacol"},{"issue":"23","key":"9524_CR28","doi-asserted-by":"publisher","first-page":"9809","DOI":"10.1158\/0008-5472.CAN-08-1008","volume":"68","author":"FX Mahon","year":"2008","unstructured":"Mahon FX, Hayette S, Lagarde V, Belloc F, Turcq B, Nicolini F, Belanger C, Manley PW, Leroy C, Etienne G, Roche S, Pasquet JM (2008) Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression. Cancer Res 68(23):9809\u20139816. doi:10.1158\/0008-5472.CAN-08-1008","journal-title":"Cancer Res"},{"issue":"7","key":"9524_CR29","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2174\/138945006777709566","volume":"7","author":"H Lage","year":"2006","unstructured":"Lage H (2006) MDR1\/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance. Curr Drug Targets 7(7):813\u2013821. doi:10.1016\/j.ics.2005.02.019","journal-title":"Curr Drug Targets"},{"issue":"5","key":"9524_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/sj.clpt.6100296","volume":"83","author":"M Mimeault","year":"2008","unstructured":"Mimeault M, Hauke R, Batra SK (2008) Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies. Clin Pharmacol Ther 83(5):673\u2013691. doi:10.1038\/sj.clpt.6100296","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"9524_CR31","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.tips.2009.07.003","volume":"30","author":"MD Hall","year":"2009","unstructured":"Hall MD, Handley MD, Gottesman MM (2009) Is resistance useless? Multidrug resistance and collateral sensitivity. Trends Pharmacol Sci 30(10):546\u2013556. doi:10.1016\/j.tips.2009.07.003","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"9524_CR32","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2174\/138945006777709593","volume":"7","author":"S Nobili","year":"2006","unstructured":"Nobili S, Landini I, Giglioni B, Mini E (2006) Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets 7(7):861\u2013879. doi:10.2174\/138945006777709593","journal-title":"Curr Drug Targets"},{"key":"9524_CR33","unstructured":"American Society of Health-System Pharmacists (ASHP). http:\/\/www.ncbi.nlm.nih.gov\/bookshelf\/br.fcgi?book\u2009=\u2009meds. Accessed 5 January 2010"},{"issue":"1","key":"9524_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/10245330400026204","volume":"11","author":"HA Abd El-Ghaffar","year":"2006","unstructured":"Abd El-Ghaffar HA, Aladle DA, Farahat SE, El-Hady A (2006) P-glycoprotein (P-170) expression in acute leukemias. Hematology 11(1):35\u201341. doi:10.1080\/10245330400026204","journal-title":"Hematology"},{"issue":"2","key":"9524_CR35","first-page":"433","volume":"19","author":"K Ugocsai","year":"2005","unstructured":"Ugocsai K, Varga A, Moln\u00e1r P, Antus S, Moln\u00e1r J (2005) Effects of selected flavonoids and carotenoids on drug accumulation and apoptosis induction in multidrug-resistant colon cancer cells expressing MDR1\/LRP. In Vivo 19(2):433\u2013438","journal-title":"In Vivo"},{"issue":"1","key":"9524_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10863-006-9055-9","volume":"39","author":"DM Nguyen","year":"2007","unstructured":"Nguyen DM, Hussain M (2007) The role of the mitochondria in mediating cytotoxicity of anti-cancer therapies. J Bioenerg Biomembr 39(1):13\u201321. doi:10.1007\/s10863-006-9055-9","journal-title":"J Bioenerg Biomembr"},{"key":"9524_CR37","doi-asserted-by":"publisher","unstructured":"Liu XD, Sun H, Liu GT (2009) 5-Bromotetrandrine enhances the sensitivity of doxorubicin-induced apoptosis in intrinsic resistant human hepatic cancer Bel7402 cells. Cancer Lett. Dec 2. [Epub ahead of print]. doi:10.1016\/j.canlet.2009.11.001","DOI":"10.1016\/j.canlet.2009.11.001"},{"key":"9524_CR38","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ejca.2005.09.017","volume":"8","author":"M Volm","year":"1996","unstructured":"Volm M, Zintl F, Sauerbrey A (1996) Resistance-related proteins in initial and relapsed childhood acute lymphoblastic. leukemia. Int J Oncol 8:331\u2013335. doi:10.1016\/j.ejca.2005.09.017","journal-title":"Int J Oncol"},{"issue":"4","key":"9524_CR39","first-page":"1086","volume":"94","author":"CP Leith","year":"1999","unstructured":"Leith CP, Kopecky KJ, Chen IM, Eijdems L, Slovak ML, McConnell TS, Head DR, Weick J, Grever MR, Appelbaum FR, Willman CL (1999) Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1\/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study. Blood 94(3):1086\u20131099","journal-title":"Blood"},{"issue":"21","key":"9524_CR40","doi-asserted-by":"publisher","first-page":"7764","DOI":"10.1158\/1078-0432.CCR-04-1895","volume":"11","author":"Z Benderra","year":"2005","unstructured":"Benderra Z, Faussat AM, Sayada L, Perrot JY, Tang R, Chaoui D, Morjani H, Marzac C, Marie JP, Legrand O (2005) MRP3, BCRP, and P-Glycoprotein activities are prognostic factors in adult acute myeloid leukemia. Clin Cancer Res 11(21):7764\u20137772. doi:10.1158\/1078-0432.CCR-04-1895","journal-title":"Clin Cancer Res"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-010-9524-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-010-9524-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-010-9524-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-010-9524-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T05:07:58Z","timestamp":1678511278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-010-9524-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["9524"],"URL":"https:\/\/doi.org\/10.1007\/s10637-010-9524-1","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,4]]},"assertion":[{"value":"10 March 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}